Bath & Body Works (NYSE:BBWI) Releases Q1 2025 Earnings Guidance

Bath & Body Works (NYSE:BBWI) updated its first quarter 2025 earnings guidance on Monday. The company provided EPS guidance of 0.490-0.490 for the period, compared to the consensus EPS estimate of 0.420. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Bath & Body Works also updated its FY 2025 guidance to 3.250-3.600 EPS.

Analysts Set New Price Targets

Several analysts have recently issued reports on BBWI shares. Piper Sandler set a $39.00 target price on Bath & Body Works and gave the stock an “overweight” rating in a report on Thursday. The Goldman Sachs Group decreased their price objective on shares of Bath & Body Works from $49.00 to $42.00 and set a “buy” rating on the stock in a research note on Tuesday, April 22nd. Barclays cut their target price on Bath & Body Works from $38.00 to $31.00 and set an “equal weight” rating for the company in a research note on Monday, May 12th. Morgan Stanley decreased their price target on Bath & Body Works from $49.00 to $43.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 6th. Finally, Raymond James reduced their price objective on Bath & Body Works from $46.00 to $37.00 and set an “outperform” rating on the stock in a research note on Thursday, April 17th. Four analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, Bath & Body Works presently has an average rating of “Moderate Buy” and a consensus price target of $41.94.

Bath & Body Works Price Performance

Shares of Bath & Body Works stock traded down $0.42 during trading on Monday, hitting $33.34. The company’s stock had a trading volume of 1,728,197 shares, compared to its average volume of 4,831,763. The stock has a market cap of $7.10 billion, a price-to-earnings ratio of 8.13, a price-to-earnings-growth ratio of 0.92 and a beta of 1.87. Bath & Body Works has a 52 week low of $24.96 and a 52 week high of $52.99. The stock has a 50-day moving average price of $29.97 and a two-hundred day moving average price of $34.00.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. On average, equities analysts predict that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.40%. Bath & Body Works’s dividend payout ratio is presently 21.98%.

Bath & Body Works declared that its board has authorized a stock buyback program on Thursday, February 27th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to purchase up to 6.4% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its stock is undervalued.

Hedge Funds Weigh In On Bath & Body Works

An institutional investor recently raised its position in Bath & Body Works stock. Goldman Sachs Group Inc. boosted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 15.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 645,970 shares of the company’s stock after buying an additional 87,529 shares during the period. Goldman Sachs Group Inc. owned approximately 0.30% of Bath & Body Works worth $19,586,000 as of its most recent SEC filing. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.